164 related articles for article (PubMed ID: 8673537)
1. Replacing time since human immunodeficiency virus infection by marker values in predicting residual time to acquired immunodeficiency syndrome diagnosis. Multicenter AIDS Cohort Study.
Shi M; Taylor JM; Currier RJ; Tang H; Hoover DR; Chmiel JS; Bryant JL
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jul; 12(3):309-16. PubMed ID: 8673537
[TBL] [Abstract][Full Text] [Related]
2. Dependence of the hazard of AIDS on markers.
Yong FH; Taylor JM; Bryant JL; Chmiel JS; Gange SJ; Hoover D
AIDS; 1997 Feb; 11(2):217-28. PubMed ID: 9030370
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV
N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191
[TBL] [Abstract][Full Text] [Related]
4. Immunologic markers of progression to acquired immunodeficiency syndrome are time-dependent and illness-specific.
Krämer A; Biggar RJ; Hampl H; Friedman RM; Fuchs D; Wachter H; Goedert JJ
Am J Epidemiol; 1992 Jul; 136(1):71-80. PubMed ID: 1384311
[TBL] [Abstract][Full Text] [Related]
5. A 90-kDa protein serum marker for the prediction of progression to AIDS in a cohort of HIV-1+ homosexual men.
Briggs NC; Natoli C; Tinari N; D'Egidio M; Goedert JJ; Iacobelli S
AIDS Res Hum Retroviruses; 1993 Sep; 9(9):811-6. PubMed ID: 7504933
[TBL] [Abstract][Full Text] [Related]
6. Early levels of CD4, neopterin, and beta 2-microglobulin indicate future disease progression.
Shi M; Taylor JM; Fahey JL; Hoover DR; Muñoz A; Kingsley LA
J Clin Immunol; 1997 Jan; 17(1):43-52. PubMed ID: 9049785
[TBL] [Abstract][Full Text] [Related]
7. Relationship and prognostic value of endogenous interferon-alpha, beta 2-microglobulin, and neopterin serum levels in patients with Kaposi sarcoma and AIDS.
Krown SE; Niedzwiecki D; Bhalla RB; Flomenberg N; Bundow D; Chapman D
J Acquir Immune Defic Syndr (1988); 1991; 4(9):871-80. PubMed ID: 1895208
[TBL] [Abstract][Full Text] [Related]
8. Tracking of markers and onset of disease among HIV-1 seroconverters.
Galai N; Muñoz A; Chen K; Carey VJ; Chmiel J; Zhou SY
Stat Med; 1993 Nov; 12(22):2133-45. PubMed ID: 7906051
[TBL] [Abstract][Full Text] [Related]
9. Virologic and serologic markers of rapid progression to AIDS after HIV-1 seroconversion.
Farzadegan H; Henrard DR; Kleeberger CA; Schrager L; Kirby AJ; Saah AJ; Rinaldo CR; O'Gorman M; Detels R; Taylor E; Phair JP; Margolick JB
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Dec; 13(5):448-55. PubMed ID: 8970472
[TBL] [Abstract][Full Text] [Related]
10. The predictive value of several markers in the progression to acquired immunodeficiency syndrome.
Planella T; Cortés M; Martínez-Brú C; Barrio J; Sambeat MA; González-Sastre F
Clin Chem Lab Med; 1998 Mar; 36(3):169-73. PubMed ID: 9589805
[TBL] [Abstract][Full Text] [Related]
11. Neopterin and beta 2-microglobulin as prognostic indices in human immunodeficiency virus type 1 infection.
Fuchs D; Krämer A; Reibnegger G; Werner ER; Dierich MP; Goedert JJ; Wachter H
Infection; 1991; 19 Suppl 2():S98-102. PubMed ID: 1673120
[TBL] [Abstract][Full Text] [Related]
12. Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection.
Whittle H; Egboga A; Todd J; Corrah T; Wilkins A; Demba E; Morgan G; Rolfe M; Berry N; Tedder R
AIDS; 1992 Jul; 6(7):685-9. PubMed ID: 1354448
[TBL] [Abstract][Full Text] [Related]
13. Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression.
Liu Z; Cumberland WG; Hultin LE; Prince HE; Detels R; Giorgi JV
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Oct; 16(2):83-92. PubMed ID: 9358102
[TBL] [Abstract][Full Text] [Related]
14. [Lymphocyte subpopulations, neopterin, and beta-2-microglobulin: relationship with clinical stage, risk of progression to AIDS and presence of active infection in HIV infection].
Antón F; Labarga P; Pinilla J; Soto MJ; Leoz A; del Cura J; Borque L; Milazzo A
Enferm Infecc Microbiol Clin; 1993; 11(7):373-7. PubMed ID: 8104488
[TBL] [Abstract][Full Text] [Related]
15. The 90K tumor-associated antigen and clinical progression in human immunodeficiency virus infection.
Iacobelli S; Ullrich A; Tinari N; Ortona L; Tamburrini E; D'Egidio M; Ghinelli F; Sighinolfi L; Piazza M; Chirianni A
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(4):450-6. PubMed ID: 7583441
[TBL] [Abstract][Full Text] [Related]
16. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection.
Mellors JW; Muñoz A; Giorgi JV; Margolick JB; Tassoni CJ; Gupta P; Kingsley LA; Todd JA; Saah AJ; Detels R; Phair JP; Rinaldo CR
Ann Intern Med; 1997 Jun; 126(12):946-54. PubMed ID: 9182471
[TBL] [Abstract][Full Text] [Related]
17. Serum neopterin changes in HIV-infected subjects: indicator of significant pathology, CD4 T cell changes, and the development of AIDS.
Melmed RN; Taylor JM; Detels R; Bozorgmehri M; Fahey JL
J Acquir Immune Defic Syndr (1988); 1989; 2(1):70-6. PubMed ID: 2783972
[TBL] [Abstract][Full Text] [Related]
18. Immune activation markers and AIDS prognosis.
Osmond DH; Shiboski S; Bacchetti P; Winger EE; Moss AR
AIDS; 1991 May; 5(5):505-11. PubMed ID: 1677808
[TBL] [Abstract][Full Text] [Related]
19. [Serum neopterin and beta2-microglobulin concentration as "prognostic markers" of AIDS].
Halota W; Jaruga B; Pawłowska M
Pol Merkur Lekarski; 2002 Aug; 13(74):126-8. PubMed ID: 12420343
[TBL] [Abstract][Full Text] [Related]
20. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.
Jacobson MA; Bacchetti P; Kolokathis A; Chaisson RE; Szabo S; Polsky B; Valainis GT; Mildvan D; Abrams D; Wilber J
BMJ; 1991 Jan; 302(6768):73-8. PubMed ID: 1671651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
